EPINEPHRINE
EPINEPHRINE
Approval overview EPINEPHRINE is listed in Drugs@FDA under application 217485 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 30MG BASE/30ML (EQ 1MG BASE/ML) Sponsor AMNEAL Submission history Latest submission status date: 2025-10-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview EPINEPHRINE is listed in Drugs@FDA under application 217485 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 30MG BASE/30ML (EQ 1MG BASE/ML) Sponsor AMNEAL Submission history Latest submission status date: 2025-10-14 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.